StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3012% below fair value
$25.56−0.61 (-2.33%)

Close on Nov 20, 2026Market cap $2.47BP/E –Yield –

IDEAYA Biosciences gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for IDEAYA Biosciences

IDEAYA Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More IDEAYA Biosciences figures

See a number that looks wrong?